A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Endometrial Cancer|Lung Cancer|Colo-rectal Cancer|Head and Neck Cancer
Interventions: DRUG: Serabelisib|DRUG: Canagliflozin 300mg
Sponsor: Petra Pharma